120 related articles for article (PubMed ID: 2963534)
1. Implementation of the group sequential methodology in a randomized trial in metastatic colorectal carcinoma.
Kemeny N; Reichman B; Geller N; Hollander P
Am J Clin Oncol; 1988 Feb; 11(1):66-72. PubMed ID: 2963534
[TBL] [Abstract][Full Text] [Related]
2. Metastatic colorectal carcinoma. A prospective randomized trial of Methyl-CCNU, 5-Fluorouracil (5-FU) and vincristine (MOF) versus MOF plus streptozotocin (MOF-Strep).
Kemeny N; Yagoda A; Braun D
Cancer; 1983 Jan; 51(1):20-4. PubMed ID: 6217886
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy of large bowel carcinoma--fluorouracil (FU) + hydroxyurea (HU) vs. methyl-CCNU, oncovin, fluorouracil, and streptozotocin (MOF-Strep). An Eastern Cooperative Oncology Group study.
Engstrom PF; MacIntyre JM; Schutt AJ; Douglass HO
Am J Clin Oncol; 1985 Oct; 8(5):358-61. PubMed ID: 2932908
[TBL] [Abstract][Full Text] [Related]
4. Methyl-CCNU, 5-fluorouracil, vincristine, and streptozocin (MOF-STREP) in metastatic colo-rectal carcinoma.
Weltz MD; Perry DJ; Blom J; Butler WM
J Clin Oncol; 1983 Feb; 1(2):135-7. PubMed ID: 6230421
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of methyl-CCNU, vincristine, 5-fluorouracil, and streptozotocin in advanced colorectal cancer. By the Gastrointestinal Tumor Study Group.
J Clin Oncol; 1984 Jul; 2(7):770-3. PubMed ID: 6234380
[TBL] [Abstract][Full Text] [Related]
6. Treatment of advanced colorectal carcinoma with actinomycin D, vincristine, methyl-CCNU, and methotrexate.
Craig JB; Jackson DV; Richards FR; Muss HB; White DR; Cooper MR; Stuart JJ; Spurr CL
Am J Clin Oncol; 1987 Feb; 10(1):44-6. PubMed ID: 3825991
[TBL] [Abstract][Full Text] [Related]
7. A randomized study of two different schedules of methyl CCNU, 5-FU and vincristine for metastatic colorectal carcinoma.
Kemeny N; Yagoda A; Braun D; Golbey R
Cancer; 1979 Jan; 43(1):78-82. PubMed ID: 367575
[TBL] [Abstract][Full Text] [Related]
8. A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinoma.
Buroker TR; Moertel CG; Fleming TR; Everson LK; Cullinan SA; Krook JE; Mailliard JA; Marschke RF; Klaassen DJ; Laurie JA
J Clin Oncol; 1985 Dec; 3(12):1624-31. PubMed ID: 2933492
[TBL] [Abstract][Full Text] [Related]
9. Therapy for metastatic colorectal carcinoma with a combination of methyl-CCNU, 5-fluorouracil vincristine and streptozotocin (MOF-Strep).
Kemeny N; Yagoda A; Braun D; Golbey R
Cancer; 1980 Mar; 45(5):876-81. PubMed ID: 7260839
[TBL] [Abstract][Full Text] [Related]
10. A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma.
Petrelli N; Herrera L; Rustum Y; Burke P; Creaven P; Stulc J; Emrich LJ; Mittelman A
J Clin Oncol; 1987 Oct; 5(10):1559-65. PubMed ID: 2443619
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy of advanced colorectal cancer. A randomized trial of sequential methotrexate and 5-fluorouracil.
Mackintosh J; Coates A; Swanson C; Raghavan D; Tattersall MH
Am J Clin Oncol; 1987 Jun; 10(3):210-2. PubMed ID: 3296732
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy with methotrexate and 5-fluorouracil: a prospective randomized clinical trial of order of administration.
Coates AS; Tattersall MH; Swanson C; Hedley D; Fox RM; Raghavan D
J Clin Oncol; 1984 Jul; 2(7):756-61. PubMed ID: 6376719
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of methyl-CCNU, vincristine, 5-fluorouracil, and streptozotocin (MOF-Strep) in patients with disseminated pancreatic carcinoma.
Sordillo PP; Magill GB
Am J Clin Oncol; 1982 Jun; 5(3):277-9. PubMed ID: 6282110
[TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy (5-fluorouracil, methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the Piedmont Oncology Association.
Richards F; Case LD; White DR; Muss HB; Spurr CL; Jackson DV; Cooper MR; Zekan P; Cruz J; Stuart JJ
J Clin Oncol; 1986 Apr; 4(4):565-70. PubMed ID: 3514806
[TBL] [Abstract][Full Text] [Related]
15. A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma.
Erlichman C; Fine S; Wong A; Elhakim T
J Clin Oncol; 1988 Mar; 6(3):469-75. PubMed ID: 3280741
[TBL] [Abstract][Full Text] [Related]
16. Systemic cytostatic drug therapy in liver cancer.
Glimelius B
Ann Chir Gynaecol Suppl; 1986; 200():69-73. PubMed ID: 3014989
[No Abstract] [Full Text] [Related]
17. Therapy of advanced colorectal carcinoma with 5-fluorouracil and cyclophosphamide in combination with either CCNU or methotrexate.
White DR; Richards F; Muss HB; Cooper MR; Spurr CL
Cancer; 1980 Feb; 45(4):662-5. PubMed ID: 6986968
[TBL] [Abstract][Full Text] [Related]
18. [A clinical study (phase II) of a combination of 5-fluorouracil, vincristine and methyl CCNU in patients with advanced carcinoma of the large intestine].
Roth A; Kolarić K
Lijec Vjesn; 1983 Jun; 105(6):244-6. PubMed ID: 6633141
[No Abstract] [Full Text] [Related]
19. Sequential chemoimmunotherapy of colorectal cancer: evaluation of methotrexate, Baker's Antifol and levamisole.
Bedikian AY; Valdivieso M; Mavligit GM; Burgess MA; Rodriguez V; Bodey GP
Cancer; 1978 Nov; 42(5):2169-76. PubMed ID: 363254
[TBL] [Abstract][Full Text] [Related]
20. Advanced colorectal carcinoma. A prospective randomized trial of sequential methotrexate, 5-fluorouracil, and leucovorin versus 5-fluorouracil alone.
Machiavelli M; Leone BA; Romero A; Rabinovich MG; Vallejo CT; Bianco A; Pérez JE; Rodríguez R; Cuevas MA; Alvarez LA
Am J Clin Oncol; 1991 Jun; 14(3):211-7. PubMed ID: 2031508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
